The Veteran's appeal for service connection of immune thrombocytopenic purpura is remanded due to insufficient evidence. His claim for TDIU remains under review.
The deciding factor: Medical opinion and examination are needed to determine if the Veteran's current condition has a nexus to his military service or any toxic exposure risk activities (TERA).
- Claimed conditions
- immune thrombocytopenic purpura
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 8, 2023
- Citation
- A23031478
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A23031478.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Board has denied the Veteran's claims for service connection for diabetes mellitus and immune thrombocytopenic purpura, finding that there is no evidence of exposure to herbicides or other toxic agents during service. The Board also found insufficient medical evidence linking these conditions to service.
- Whole decision: Denied
The Board denied the Veteran's claims for earlier effective dates for service connection and ratings for various conditions, including coronary artery disease, congestive heart failure, ischemic heart disease, diabetes mellitus, perforated tympanic membrane, biclonal gammopathy with multiple myeloma, pulmonary nodules of the right lung, and immune thrombocytopenic purpura. The effective dates were not earlier than September 19, 2011.
- Whole decision: Denied
The Board has determined that the Veteran's endocarditis and immune thrombocytopenic purpura are not related to his active duty service, including as due to herbicide exposure. As a result, these conditions cannot be granted presumptively under VA law.
- Whole decision: Remanded (sent back)
The Board has remanded the case due to the need for additional development, including obtaining SSA records and providing proper notice regarding secondary service connection.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.